FDA 21 CFR Part 820 (QSR) Consultant in Pune
The medical device industry in Pune, India is a rapidly growing sector that is driven by the increasing demand for healthcare products worldwide. Companies in this industry are required to comply with strict regulations set by the US FDA under 21 CFR Part 820 to access the device in US market, which outlines quality system regulations for medical device manufacturers.
With the help of Operon Strategist as a experienced FDA consultants in Pune, medical device companies can navigate these regulations and implement effective quality management systems to ensure that their products meet all necessary safety and efficacy requirements.
What is FDA 21 CFR Part 820?
21 CFR Part 820, also known as the Quality System Regulation (QSR), is a set of regulations established by the US Food and Drug Administration (FDA) that outlines the requirements for medical device manufacturers to establish and maintain a quality management system (QMS). The QSR applies to all medical devices sold in the United States, regardless of whether they are manufactured domestically or imported.
Looking for Consultant in Pune?
Let’s have word about your project
This process typically involves a team of experts, including engineers, scientists, regulatory specialists, and quality assurance professionals, who work together to ensure that the medical device is safe, effective, and meets the needs of patients and healthcare providers.
How Operon Strategist can assist in FDA 21 CFR Part 820(QSR)
Role in FDA 21 CFR Part 820 – Quality System Regulations:
- Operon Strategist does an initial gap analysis of the existing system to determine the extent of development of the quality system.
- Provide 21 CFR 820 training courses in which we guide the clients through documentation & help them to effectively implement it through the various functions of the company.
- Conducted a mock audit to test the effectiveness of the implementation of Part 820 requirements.
- Provide post-inspection guidance to clients to help them close any non-conformance observed during the audit.
- FDA 21 CFR Part 820 helps manufacturers to build and follow quality systems to help assure that their products consistently meet applicable requirements and specifications.
FAQs
What is FDA 21 CFR Part 820?
FDA 21 CFR Part 820, also known as the Quality System Regulation (QSR), is a regulation issued by the U.S. Food and Drug Administration that establishes Quality Management System (QMS) requirements for medical device manufacturers selling products in the United States.
Why is 21 CFR Part 820 important for Pune-based manufacturers?
Compliance allows Pune-based medical device manufacturers to access the US market, maintain high product quality standards, reduce regulatory risks, and strengthen international credibility.
What does 21 CFR Part 820 cover?
It includes requirements related to design controls, production and process controls, packaging, labeling, storage, installation, servicing, CAPA (Corrective and Preventive Actions), complaint handling, and documentation systems.
Is compliance mandatory for exporting medical devices to the US?
Yes. All manufacturers—whether based in India or internationally—must comply with 21 CFR Part 820 if they intend to sell medical devices in the United States.
How long does it take to implement FDA 21 CFR Part 820?
The implementation timeline depends on the organization’s existing Quality Management System maturity. Generally, it may take several months to complete documentation, process implementation, employee training, and audit readiness preparation.